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CD4 T cell death or survival following initial HIV infection is crucial for the development of
viral reservoirs and latent infection, making its evaluation critical in devising strategies for
HIV cure. Here we infected primary CD4 T cells with a wild-type HIV-1 and investigated the
death and survival mechanisms in productively infected and bystander cells during early
HIV infection. We found that HIV-infected cells exhibited increased programmed cell
death, such as apoptosis, pyroptosis, and ferroptosis, than uninfected cells. However,
productively infected (p24+) cells and bystander (p24-) cells displayed different patterns of
cell death due to differential expression of pro-/anti-apoptotic proteins and signaling
molecules. Cell death was triggered by an aberrant DNA damage response (DDR), as
evidenced by increases in gH2AX levels, which inversely correlated with telomere length
and telomerase levels during HIV infection. Mechanistically, HIV-infected cells exhibited a
gradual shortening of telomeres following infection. Notably, p24+ cells had longer
telomeres compared to p24- cells, and telomere length positively correlated with the
telomerase, pAKT, and pATM expressions in HIV-infected CD4 T cells. Importantly,
blockade of viral entry attenuated the HIV-induced inhibition of telomerase, pAKT, and
pATM as well as the associated telomere erosion and cell death. Moreover, ATM inhibition
promoted survival of HIV-infected CD4 T cells, especially p24+ cells, and rescued
telomerase and AKT activities by inhibiting cell activation, HIV infection, and DDR.
These results indicate that productively infected and bystander CD4 T cells employ
different mechanisms for their survival and death, suggesting a possible pro-survival, proreservoir mechanism during early HIV infection.
Keywords: AKT, ATM, HIV, telomerase, telomere, T cell death, survival
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mechanism is likely to be due to an interplay between direct viral
cytopathogenicity and indirect inﬂammatory stimulation. Thus,
investigating the fundamental mechanisms underlying CD4 T cell
survival or death during early HIV infection will enhance our
understanding of how HIV establishes its reservoirs, which is
essential to devising strategies for eliminating HIV latency.
Using our established cellular model of in vitro HIV infection in
primary CD4 T cells with or without ART (17), we investigated the
mechanisms of telomere dynamics in CD4 T cell homeostasis and
the role of TCR signaling pathways in cell death during early HIV
infection. We analyzed the fate of productively infected (p24+) and
bystander (p24-) CD4 T cells, the dynamics of their telomeres, and
the state of TCR signaling pathways during early HIV infection. We
discovered that HIV-infected cells exhibit increased programmed
cell death, with gradual shortening of telomeres and inhibition of
the TCR signaling pathways. Interestingly, productively infected
CD4 T cells showed remarkably prolonged telomeres, increased
levels of telomerase, and greater activation of TCR signaling
pathways compared to bystander CD4 T cells, suggesting the
involvement of cell survival and pro-reservoir mechanisms. These
results indicate that telomere dynamics control T cell fate and that
HIV-infected and uninfected cells behave differently in their survival
and death mechanisms during early infection. Thus, disrupting
these mechanisms may offer novel strategies to promote HIVinfected cell death so as to eliminate the virus reservoirs and rescue
bystander cells to maintain the host immunity.

INTRODUCTION
HIV infection induces a gradual depletion of CD4 T cells, leading
to decline of host immunity which increases the risk of
opportunistic infections and elevates mortality (1, 2). HIV
infection, if left untreated, can lead to AIDS over a period of 810 years. This disease progression was originally thought to be a
result of slow but inexorable virus-mediated CD4 T cell
destruction. However, recent studies have shown that massive
CD4 T cell depletion occurs quite early in HIV-1 infection (1, 2).
In most HIV-infected individuals, this initial phase of
destruction is counteracted by CD4 T cell regeneration and
compensatory responses. However, this T compensatory
mechanism is short-lived, promotes immune activation and
dysregulation, and cannot restore all functionally competent
CD4 T cell populations. Ultimately, these processes disrupt
CD4 T cell homeostasis and reduce the levels of critical
effector/memory T cells below the threshold necessary to
prevent opportunistic infections or associated pathologies.
Antiretroviral therapy (ART) suppresses HIV replication and
enhances CD4 T cell recovery. However, complete CD4 T cell
recovery or immune reconstitution does not always occur despite a
successful ART-mediated control of HIV replication (3, 4). In
addition, with ART treatment HIV develops latent infection with
the existence of viral reservoirs, thus posing a constant risk of viral
rebound in the absence of optimal ART. these HIV reservoirs
represent a major barrier to HIV eradication and likely drive
chronic inﬂammation and incomplete immune reconstitution (5,
6). As the challenges inherent to these viral reservoirs have come to
be recognized over the last decade, it is clear that evaluations of the
fundamental mechanisms facilitating HIV reservoir formation is
critical to understanding HIV persistence.
HIV latency is established early in both resting and activated
primary CD4 T cells, and HIV reservoir sizes and persistence are
driven by T cell survival and homeostatic proliferation (7, 8).
One possible mechanism underlying the development of these
reservoirs is the preservation of the infected CD4 memory T cells
that carry integrated provirus and survive cell death (5–9). While
these viral reservoirs can be eliminated through virus-induced
cytopathogenic effects or T cell receptor (TCR) activationinduced cell death, their reversion to a virus-silenced and/or a
cell-resting state facilitates survival during HIV latency.
Unknown machineries are likely to contribute to the survival
of select HIV-infected cells, leading to the establishment of
HIV reservoirs.
We have recently shown that chronic viral (HIV, HBV, HCV)
infection can induce topological DNA damage and telomere erosion
due to deﬁciency of topoisomerases (such as Top1 and Top2a),
telomere shelterin protein (TRF2), and DNA repair kinases (such as
ATM and ATR), all of which can lead to telomere shortening,
genomic instability, and cell apoptosis (10–17). Productively
infected T cells, however, can also affect bystander cells through
secretion of inﬂammatory cytokines or induction of inhibitory
molecules (18–20). Thus, immunodeﬁciency appears to be an
overt result of CD4 T cell homeostasis in productively infected
and bystander T cells, affecting their sensitivity to cell activation,
proliferation, and vulnerability to cell death. This immunodeﬁciency
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METHODS
CD4 T Cell Isolation and HIV-1 Infection
Peripheral blood mononuclear cells (PBMCs) were isolated from
whole blood of healthy subjects (HS; negative for HBV, HCV, and
HIV infections) supplied by BioIVT (Gray, TN) using Ficoll
density centrifugation (GE Healthcare; Piscataway, NJ). CD4 T
cells were isolated from PBMCs using CD4 T Cell Negative
Isolation Kit (Miltenyi Biotec, Auburn, CA). The CD4 T cells
were cultured in complete RPMI-1640 medium containing 10%
FBS (Atlanta Biologicals; Flowery Branch, GA), 100 IU/ml
penicillin, and 2 mM L-glutamine (Thermo Scientiﬁc, Logan,
Utah). The cells were stimulated with 1 µg/ml anti-CD3, 1 µg/ml
anti-CD28 (BD Bioscience, San Jose, CA), 100 IU IL-2 (SigmaAldrich, St. Louis, MO) for 48 h. The cells were infected with
HIV-1 as described previously (17). Brieﬂy, 20 µg of pNL4-3
plasmid [contains full-length HIV-1 DNA inserted into a pUC18
vector) obtained from the NIH AIDS Reagent Program, originally
deposited by Dr. Malcolm Martin (21)]. The plasmid DNA was
transfected into the HEK293T cells using the polyethylenimine
(PEI) method. The supernatants of HIV-transfected HEK293T
cells were used to infect SupT-1 cells to prepare the virus-stock
for CD4 T cell infection using the spinoculation method (21).
Approximately 1 x 106 CD4 T cells were infected with SupT-1
supernatant containing 1 x 106 HIV-1 in culture plates using
centrifugation at 1620 x g in a 37°C incubator. After 2 h of
spinoculation, the supernatants were removed to discard the
unattached viruses. Complete RPMI-1640 medium was added,

2

February 2021 | Volume 11 | Article 626431

Cao et al.

CD4 T Cell Live or Death

and the cells were harvested at days 3, 5, and 7 for analysis. For
blocking the virus entry or the ATM pathway, Maraviroc (2 µM)
and T-20 (250 nM) (from the NIH AIDS Reagent Program), or
ATM inhibitor (KU-60019, 10 mM) (Abcam, Cambridge, MA)
were added to the culture after 2 h of inoculation. For HIV
protein treatment, CD4 T cells were incubated with recombinant
HIV proteins (gp120, p24, Tat, p7, Nef, and Gag) for 3, 5, and 7
days, followed by measuring telomere length, hTERT, pAKT, and
pATM by ﬂow cytometry.

immunoblotting. Primary and secondary antibodies included
anti-gH2AX, hTERT and horseradish peroxide-conjugated
antibody (Cell Signaling). Images were captured using
ChemiDoc™ XRS+ System (Bio-Rad).

Southern Blot
Southern blot was performed to determine telomere terminal
restriction fragments (TRF), as previously described (22). Brieﬂy,
after cell treatment or HIV-infection, DNA was extracted and
digested with HinfI and RsaI restriction enzymes to remove nontelemetric DNA. The DNA fragments were separated on 0.5%
agarose gel, blotted, detected by a DIG-labeled (CCCTAA)3
probe, and visualized by chemiluminescence.

Flow Cytometry
For the apoptosis assay, cells were stained with PE Annexin V
Apoptosis Detection Kit I (BD Bioscience, San Jose, CA). Brieﬂy,
the cells were harvested, washed with DPBS, labeled with
Annexin V-PE and 7-AAD in binding buffer, and then
analyzed by AccuriC6 Plus ﬂow cytometer (BD Bioscience)
and FlowJo software (Tree Star, Ashland, OR). For nuclear
protein staining, the cells were ﬁxed in Fixation Buffer
(BioLegend, San Diego, CA), permeabilized with Fixation/
Permeabilization Concentrate and Diluent (Thermo Fisher
Scientiﬁc, Waltham, MA), and stained with Anti-HIV-1 p24
monoclonal antibody (KC57)-PE (NIH AIDS Reagent Program),
gH2AX, PD-1 (BioLegend), pAKT, active caspase-3 kit (Thermo
Fisher Scientiﬁc), active caspase-1 kit (Abcam, Cambridge, MA),
hTERT (Rockland Immunochemicals, Limerick, PA), GPx-4,
Bcl-2, Mcl-1, p-Bad, Bax, Ox40, Nur77, Birc5 and pATM
(Santa Cruze Biotechnology, Dallas, TX). Isotype control
antibodies (Thermo Fisher Scientiﬁc) and single staining
controls were used to determine background staining and to
adjust multicolor compensation as a gating strategy.

Statistical Analysis
The data were analyzed using Prism 7 software and are presented
as mean ± S.E. (standard error). The outliers were identiﬁed by
the ROUT method (Q = 1.000%) and excluded from the analysis.
Student’s t-test was used to compare means of two independent
groups with equal variances, and Welch’s correction was utilized
if unequal variances were found. Comparisons between two
groups for skewed data were made using the nonparametric
Mann-Whitney U test. The magnitude of correlation was
appropriately measured with Pearson’s correlation coefﬁcient
(parametric approach) or Spearman’s correlation coefﬁcient
(nonparametric approach) based on the property of the
datasets. P-values <0.05 or <0.01 were considered statistically
signiﬁcant or very signiﬁcant, respectively.

RESULTS

Flow-FISH and Meta-FISH Analysis of
Telomere Length

HIV Induces CD4 T Cell Death in
Productively Infected and Bystander Cells
During Early Infection via Different
Mechanisms

Flow-FISH analysis of telomere length was carried out as
described previously (13–17). For meta-FISH analysis, CD4 T
cells with or without HIV infection for 5 days were treated with
0.1 µg/ml colcemid for 2 h and harvested by centrifugation. The
cells were then incubated in 75 mM KCl hypotonic buffer at 37°C
for 10 or 20 min at room temperature, followed by ﬁxation in
methanol and glacial acid acetic (3:1). The cells were mounted on
microscopic slides and dried overnight before ﬁxation in 4%
formaldehyde. The slides were treated with RNaseA and Pepsin
at 37°C and then dehydrated in successive ethanol solutions of
70%, 90%, and 100%. Telomere hybridization was conducted
using a FITC-488 conjugated telomeric PNA probe (PNA Bio,
F1004 TelC-FITC488 (CCCTAA)3) at 37°C for 4 h, and the
slides were washed in hybridization buffer and kept overnight at
room temperature in Diamond AntiFade with DAPI (Invitrogen).
Approximately 50 cells in meta-phase in each treatment were
analyzed with a Leica SP8 confocal microscope, and the
percentages (%) of fragile telomeres (signal of telomeres on
chromosomes that break into segments) or telomere loss
(without visible FISH signal) were calculated.

Progressive depletion of CD4 T cells is a hallmark of untreated
HIV infection (1, 2). To understand the mechanisms of CD4 T
cell demise during HIV infection, we established an in vitro HIVinfected primary CD4 T cell culture system using a wild-type,
replicable HIV NL4-3 strain (23). We have recently shown that
HIV can productively infect human CD4 T cells, causing a DNA
damage response (DDR) and programmed cell death in a timeand dose-dependent manner (17). Here, we further investigated
the pathways of HIV-induced CD4 T cell death, including
apoptosis, pyroptosis, and ferroptosis within this model. As
shown in Figure 1A, HIV infection signiﬁcantly increased cell
death, as determined by the signiﬁcant increases in the frequency
of early apoptotic cells (Av+ 7AAD-), late apoptotic cells (Av+
7AAD+), and dead cells (Av- 7AAD+) after infection. Caspase-3
is activated by the extrinsic (death-ligand via caspase-8) as well
as intrinsic pathways (mitochondria via caspase-9 and caspase10) and plays a central role in the execution phase of cell
apoptosis (24). To conﬁrm the role of apoptosis in CD4 T cell
death, we measured active caspase-3 levels in HIV-infected and
uninfected cells over time. In line with the Av/7AAD staining,

Western Blot
Levels of gH2AX and hTERT proteins in CD4 T cells with or
without HIV infection for 5 days were determined by

Frontiers in Immunology | www.frontiersin.org

3

February 2021 | Volume 11 | Article 626431

B

D

C

E

Cao et al.

Frontiers in Immunology | www.frontiersin.org

A

F
4

G

H

CD4 T Cell Live or Death

February 2021 | Volume 11 | Article 626431

FIGURE 1 | HIV induces CD4 T cell death in productively infected and bystander cells during early infection via different mechanisms. (A) Representative dot plots (day 7) and summary of the percentage (%) of Av
and 7AAD levels in HIV-infected and uninfected CD4 T cells, as determined by ﬂow cytometry. (B, C) Representative dot plots and summary data showing active caspase-3% in productively HIV-infected (p24+) and
bystander (p24-) or uninfected cells at days 3, 5, and 7 in cultures. (D, E) Representative dot plots and summary data of active caspase-1% in HIV-infected (p24+) and bystander (p24-) or uninfected cells at day 3,
day 5, and day 7. (F–H) Representative dot plots and summary data of GPX4% in HIV-infected (p24+) and bystander (p24-) or uninfected cells at days 3, 5, and 7.
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active caspase-3 levels were signiﬁcantly increased in CD4 T cells
with HIV infection (Figure 1B). To dissect the behavior of
productively infected and bystander cells during HIV infection,
we further analyzed active caspase-3 levels in p24+ and p24- cells
in HIV culture. As shown in Figure 1C, active caspase-3 was
signiﬁcantly upregulated in both p24- cells and p24+ cells
compared to uninfected cells. These results suggest that
apoptotic death plays a critical role in CD4 T cell depletion
during early HIV infection.
Unlike apoptosis, pyroptosis is a highly inﬂammatory form of
programmed cell death that occurs most frequently upon
infection with intracellular pathogens including viruses (25).
Pyroptosis requires the function of caspase-1 to promote
maturation of IL-1b and IL-18 cytokines, and the immune cells
recognize the internal pathogens, release pro-inﬂammatory
cytokines, enlarge, burst, and die. The released cytokines
contribute to the damage of surrounding cells – a mechanism
involved in CD4 T cell depletion in HIV infection (26, 27).
Similar to active caspase-3, active caspase-1 protein was
markedly upregulated in HIV-infected cells (Figure 1D), in
both p24+ cells and p24 - cells (Figure 1E), compared to
uninfected cells. These results suggest that HIV infection also
drives CD4 T cell pyroptosis.
Ferroptosis is a type of programmed cell death characterized
by the loss of glutathione peroxidase 4 (GPX4, a lipid repair
enzyme), resulting in unchecked lipid peroxidation and eventual
cell death (28). To determine whether ferroptosis plays a role in
HIV-mediated cell death, we measured GPX4 expressions in
CD4 T cells with or without HIV infection. As expected, GPX4
levels were downregulated in CD4 T cells (Figures 1F, G),
primarily in p24- cells, with HIV infection (Figure 1H). These
results indicate increased ferroptosis, particularly in bystander T
cells, during HIV infection. Notably, we also measured cell
autophagy and found that autophagy markers (p62, LC3B)
were also dysregulated, primarily in p24- bystander cells,
during HIV infection (data not shown). Taken together, these
data indicate that HIV infection promotes CD4 T cell death via
enhancing cell apoptosis and pyroptosis (especially in p24+ cells)
and augmenting cell ferroptosis (especially in p24- cells) during
early HIV infection.

while BAD protein is pro-apoptotic, phosphorylated BAD is
anti-apoptotic, because canonical anti-apoptotic proteins such as
BCL-2/BCL-XL form heterodimers with BAD during BADdephosphorylation and this phenomenon triggers BAX/BAKmediated apoptosis. However, when BAD is phosphorylated by
AKT and BCL-2 is released, the free BCL-2 inhibits BAXtriggered apoptosis (30). Moreover, we found that Mcl-1 and
BIRC5 (Survivin) - two important survival proteins (32, 33) were signiﬁcantly downregulated in TCR-activated, uninfected
cells and upregulated in HIV-infected cells, particularly in p24+
cells (Figures 2L–O). Taken together, these results suggest that
p24+ and p24- T cells may employ different mechanisms for cell
death or survival; i.e., productively infected cells may die or
survive via upregulation of pro-apoptotic molecules or survival
proteins, respectively, whereas bystander cells may die via
suppression of anti-apoptotic proteins.

HIV Promotes CD4 T Cell Death by
Inducing DNA Damage and Disrupting
Telomeres via Inhibition of Telomerase
During Early Infection
Upon cell injury, a dynamic alteration in chromatin structure
promotes phosphorylation of the H2A histone family member X
(gH2AX) - a marker for DNA double-strand breaks (34, 35). To
determine whether HIV induces CD4 T cell death via triggering
DNA damage, we measured gH2AX during early HIV infection.
We found a substantial increase in gH2AX levels in HIV-infected
CD4 T cells (Figures 3A, B), with higher levels in p24+ cells than
in p24- cells (Figure 3C), compared to uninfected cells. The
increases in gH2AX levels were validated by western blot using
HIV-infected CD4 T cells after 5 days in culture (Figure 3D).
These results are in line with the aberrant cell death described
above (Figure 1).
Since DNA damage causes telomere shortening, and because
extremely shortened telomeres lead to cell death (10–17, 36, 37),
we hypothesized that the progressive CD4 T cell loss during HIV
infection could be, at least in part, due to accelerated telomere
erosion. In support of this notion, we have recently reported that
CD4 T cells from patients with HIV, HBV or HCV infection are
particularly vulnerable to apoptosis due to accumulation of
unrepaired telomere erosion (10–17). To determine whether
telomere erosion occurs in CD4 T cells during early HIV
infection, we measured telomere length by Flow-FISH. As
shown in Figures 3E, F, HIV-infected CD4 T cells exhibited
an initial increase followed by a gradual decrease in telomere
length after infection. Counterintuitively, productively infected
(p24+) CD4 T cells exhibited longer telomeres than p24bystander cells, which had longer telomeres at initial (day 3)
HIV infection compared to uninfected cells, and telomere
lengths were shortened in both p24+ and p24- cells by day 7
after HIV infection (Figure 3G). To conﬁrm these results, we
employed the meta-FISH approach to examine telomere status in
meta-phase CD4 T cells with or without HIV infection. As
shown in Figure 3H, the frequencies (%) of cells with fragile
telomeres (deﬁned as signals of telomeres on chromosomes that
break into segments or stretch due to faulty DNA replication) or

The Mechanisms of Survival or Death of
Productively Infected and Bystander CD4
T Cells During HIV Infection
To elucidate the mechanisms involved in cell death or survival in
productively infected or bystander cells in HIV infection, we
examined the expressions of critical pro- and anti-apoptotic or
survival proteins in HIV-infected and uninfected cells. As shown
in Figure 2A, ﬂow cytometry analysis revealed an increase in the
expression of pro-apoptotic protein Bax (29) in total CD4 T cells,
primarily in p24+ cells, in HIV culture compared to uninfected
cells (Figure 2B). In contrast, we found an overall
downregulation of anti-apoptotic proteins such as pBAD, Bcl2, OX40, and Nur77 (29–32) in total CD4 T cells, primarily in
p24- bystander cells rather than p24+ cells, in HIV culture
compared to uninfected cells (Figures 2C–K). Interestingly,
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FIGURE 2 | Expression of pro- and anti-apoptotic proteins in productively infected cells and bystander cells during HIV infection. (A, B) Summary data of Bax % in HIV-infected (p24+ -) and bystander (p24-) or
uninfected cells at days 3, 5, and 7, as determined by ﬂow cytometry. (C, D) Summary data of pBad % in HIV-infected (p24+) and bystander (p24-) or uninfected cells at days 3, 5, and 7. (E–O) Representative dot
plots and summary data of Bcl-2%, Ox40% (H, I), Nur77% (J, K), Mcl-1 (L, M), and Birc5% (N, O) in HIV-infected (p24+ vs. p24-) and uninfected cells at days 3, 5, and 7.
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FIGURE 3 | HIV causes CD4 T cell death by inducing DNA damage and disrupting telomeres via inhibition of telomerase during early viral infection. (A) Representative dot plots and gating strategy of gH2AX levels
in p24+ and p24- CD4 T cells with HIV infection at day 7. Isotype staining and uninfected CD4 T cells serve as negative controls for ﬂow cytometry. (B, C) Summary data of gH2AX % in HIV-infected (p24+ vs. p24-)
and uninfected cells at days 3, 5, and 7. (D) Western blot analysis of gH2AX levels in HIV-infected versus uninfected CD4 T cells at day 5. (E–G) Representative overlaid histograms and summary data of the mean
ﬂuorescence intensity (MFI) of telomere length in HIV-infected (p24+ or p24-) and uninfected CD4 T cells at days 3, 5, and 7, as determined by Flow-FISH. (H) Representative imaging and summary data of metaFISH analysis of the frequencies (%) of chromatin with fragile telomeres and telomere-free ends in CD4 T cells with or without HIV infection at day 5, measured by confocal microscopy. (I) Telomere length in CD4 T
cells with or without HIV infection at day 5. Telomeric DNA was treated with or without FPG and analyzed by Southern blot. (J, K, O) Representative dot plots and summary data of the human telomerase (hTERT)
% in HIV-infected (p24+ or p24-) and uninfected CD4 T cells at days 3, 5, and 7. (L) Western blot analysis of hTERT levels in HIV-infected versus uninfected CD4 T cells at day 5. (M) Correlation analysis between
hTERT expression and telomere length. (N) Correlation analysis between hTERT expression and gH2AX level in HIV-infected and uninfected cells.
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determine whether these pathways are dysregulated, we analyzed
the activation of the PI3K pathways and DNA repair kinases,
pAKT and pATM (ataxia-telangiectasia mutated) in HIVinfected and uninfected cells. We found similar expression
patterns for these proteins, including pAKT (Figures 4A–C)
and pATM (Figures 4D–F), which were inhibited in total CD4 T
cells (Figures 4B, E), especially in p24- bystander cells, but were
upregulated in p24+ cells at the initial phase (day 3) of HIV
infection, and then gradually decreased with progressive HIV
infection (Figures 4C, F). Notably, the percentages of overall
pAKT+ and pATM+ cells positively correlated with the telomere
length and telomerase expression levels in total CD4 T cells as
well as in p24+ and p24- cells during early HIV infection (Figures
4G–J). Also, pAKT and pATM exhibited similar expression
patterns in HIV-infected and uninfected cells (Figure 4K).
Concurrently with the inhibition of the TCR signaling
pathways, the expression of T cell activation marker CD25 was
also inhibited in CD4 T cells with HIV infection (Figure 4L).
These results indicate that telomere erosion and cell apoptosis
are associated with the TCR activation-mediated telomerase and
AKT/ATM dynamic changes induced by HIV infection.

telomere-free ends (deﬁned as chromatin ends that do not have
detectable telomere signal) were signiﬁcantly higher in HIVinfected CD4 T cells than uninfected cells at day 5. We also
validated these results with Southern blot using CD4 T cells
without or with HIV infection at day 5 and observed shortened
telomeres in HIV-infected cells compared to the uninfected cells
(Figure 3I). Notably, we have recently shown that repeated
telomeric sequences (TTAGGG) are enriched in guanine (G) which is particularly sensitive to oxidative stress - are
signiﬁcantly increased in aging T cells during latent HIV
infection (15) and form 8-oxoGuanine (8-oxoG) lesions that
can be digested by FPG (an 8-oxoG DNA glycosylase). Indeed,
Southern blot analysis of treated cellular DNA revealed shorten
telomeres in HIV-infected cells (Figure 3I). These results
indicate that telomeres are signiﬁcantly shortened with
oxidative DNA damage following HIV infection and that 8oxoG DNA injury may be involved in the process.
Telomeres are elongated by telomerase, which consists of
telomerase RNA (TR) and human telomerase reverse
transcriptase (hTERT), the catalytic subunit of telomerase for
telomere elongation (38). To determine whether the dynamic
changes in telomere length in CD4 T cells are due to alterations
in the telomerase expression, we measured hTERT levels in CD4
T cells with or without HIV infection using ﬂow cytometry.
Consistent with telomere length, TERT was decreased in HIVinfected cells compared to uninfected cells (Figures 3J, K).
Inhibition of hTERT expression was conﬁrmed by western blot
analysis of HIV-infected CD4 T cells (at day 5) (Figure 3L).
Notably, the percentage of hTERT+ cells positively correlated
with the median ﬂuorescence intensity (MFI) of telomere length
(Figure 3M), but negatively correlated with the frequencies of
gH2AX+ cells within the same cells (Figure 3N). Importantly,
productively infected (p24+) cells expressed greater amounts of
telomerase (even more than uninfected controls) compared to
p24- bystander cells, although the frequency of hTERT+ cells
(Figure 3O) as well as the MFI of hTERT expression (data not
shown) trended downward in both p24+ and p24- cells overtime
with HIV infection - which is in line with their telomere lengths
observed in the same cells. Taken together, these ﬁndings suggest
that HIV infection accelerates DNA damage and telomere
erosion in CD4 T cells and that productively infected cells
have longer telomeres than bystander cells due to an increase
in telomerase expression.

HIV (Gag Protein) Shortens Telomere
Length by Diminishing the Telomerase,
AKT, and ATM Activities in CD4 T Cells
How productively infected cells affect bystander cells during HIV
infection remains unknown. One possibility is that HIV particles
or proteins are released from infected cells into the culture
supernatants and inhibit those uninfected, bystander cells. To
test this possibility, we incubated uninfected CD4 T cells with
culture supernatants of HIV-infected (at day 7) or uninfected
cells in the presence of HIV-entry blockers for 3, 5, and 7 days,
followed by measuring telomere length, telomerase, AKT, and
ATM activities. Notably, without HIV entry blockers, we
observed similar changes (as shown above in Figures 3, 4) in
telomere length, telomerase, AKT, and ATM (data not shown).
We then included the HIV-entry blocker T-20 (Enfuvirtide), a
small peptide that binds to the HIV gp41 heptad repeat and
inhibits the structural changes necessary for the virus to fuse with
CD4+ T cell - and Maraviroc (Selzentry), an entry inhibitor that
speciﬁcally blocks chemokine receptor CCR5 that HIV uses as a
co-receptor to bind and enter human helper T cells - in the
culture to exclude HIV entry and infection of cells. Interestingly,
CD4 T cells treated with HIV-supernatants plus entry blockers,
which inhibit active infection but retain the live virus in the
culture media, exhibited a prolonged telomere length at day 3
and day 5 similar to early HIV-infected cells at day 3 (shown in
Figures 3D, E) compared to control cultures. However, blocking
HIV entry and infection reversed telomere length inhibition by
active HIV infection at days 5-7 (compare Figure 5A with
Figures 3D, E). Correspondingly, blocking HIV active
infection of the cells partially reversed the virus-mediated
inhibition of hTERT, pAKT, and pATM (compare Figures
5B–D with Figure 3J and Figures 4B, E, respectively). Also,
HIV infection-induced DNA damage and cell apoptosis were
partially reversed by the viral entry blockers, as evidenced by the

TCR Signaling Pathways Are Differentially
Regulated in Productively HIV-Infected
and Bystander Cells
Cells are equipped with DNA damage surveillance and repair
machineries to prevent cell death associated with genomic
instability (39–41). Accumulation of damaged DNA and
apoptotic CD4 T cells indicates an impairment of the TCR
signaling and DNA damage repair machinery during viral
infection (10–17). We thus hypothesized that progressive CD4
T cell loss during HIV infection could be, at least in part, due to
dynamic alterations in the TCR signaling pathways, potentially
leading to disruption of telomere integrity and cell longevity. To
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FIGURE 4 | T cell receptor (TCR) signaling pathways are differentially regulated in productively HIV-infected and bystander cells. (A–C) Representative dot plots and summary data of the pAKT % in HIV-infected
(p24+) and bystander (p24-) or uninfected D4 T cells at days 3, 5, and 7. (D–F) Representative dot blots and summary data of the pATM % in HIV-infected (p24+ and bystander (p24-) or uninfected CD4 T cells at
days 3, 5, and 7, by ﬂow cytometry. (G, H) Positive correlation between the MFI of telomere length and the % of pAKT or pATM expressions. (I–K) Positive correlation between the % of hTERT, pAKT, and pATM
expressions in CD4 T cells with or without HIV infection. (L) Percentage of CD25 expression in CD4 T cells with or without HIV infection.
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levels of gH2AX (Figure 5E) and AV/7AAD staining (Figure 5F)
compared to HIV-infected cells without viral blockers (Figures
3B and 1A).
Since HIV appears to induce telomere erosion through
inhibition of telomerase, AKT, and ATM activities, we next
sought to determine which speciﬁc HIV protein can drive such
an effect on CD4 T cells. To this end, we incubated primary CD4
T cells with major recombinant HIV proteins (gp120, p24, Tat,
p7, Nef, and Gag) for 3, 5, and 7 days, followed by measuring
telomere length, hTERT, pAKT, and pATM by ﬂow cytometry.
Intriguingly, among the HIV proteins examined, only HIV Gag
could signiﬁcantly shorten telomere length, only at day 7 after
treatment (Figure 5G). Correspondingly, the expressions of
hTERT, pAKT, and pATM were inhibited in primary CD4 T
cells treated with HIV Gag for 7 days (Figures 5H–J). Moreover,
the MFI of telomere length positively correlated with the
frequencies of hTERT+ cells treated with or without HIV Gag
protein for 7 days (Figure 5K), and both the frequency of
hTERT+ cells and MFI of telomere length closely correlated
with the frequency of pATM+ cells in CD4 T cells exposed to
HIV Gag protein for 7 days (Figures 5L, M). Importantly, HIV
Gag treatment inhibited T cell activation, enhanced DNA
damage, and promoted cellular apoptosis, as demonstrated by
the decreased expression of early T cell activation marker CD25
(Figure 5N) and increased staining of gH2AX (Figure 5O) and
Av (Figure 5P) in treated CD4 T cells over time. However, the
other HIV proteins, such as gp120, p24, Tat, p7, and Nef, did not
elicit such effects on telomere length and its related regulatory
proteins in multiple experiments (data not shown). Taken
together, these results indicate that HIV (Gag protein) plays a
role in the shortening of telomeres, likely through inhibition of
the hTERT and AKT/ATM signaling pathways.

treatment resulted in a partial recovery of telomere length and a
partial restoration of hTERT, pAKT, and pATM expressions,
especially at day 5-7 of HIV infection with ATMi vs. DMSO
treatment (Figures 6A–D, 4 vs. 3).
We further analyzed these expression patterns in productively
infected cells and bystander cells in HIV culture. Again, as we
observed a survival potential in productively infected cells
(Figures 3, 4), we found that p24+ cells exhibited longer
telomeres and higher levels of hTERT, pAKT, and pATM
expressions than p24- cells in HIV cultures with DMSO
treatment (Figures 6E–H, 7 vs. 5). We also observed the same
patterns in p24+ cells with the ATMi treatment (Figures 6E–H, 8
vs. 6). However, compared to HIV-infected, DMSO-treated
cultures, ATMi treatment resulted in a partial restoration of
telomere length as well as hTERT, pAKT, and pATM expressions
in both p24- cells and p24+ cells, especially at day 5-7 of HIV
infection with ATMi vs. DMSO treatment (Figures 6E–H, 6 vs. 5
and, 8 vs. 7).
Likewise, we asked whether ATM inhibition could promote
uninfected CD4 T cell death and rescue HIV-infected cells. To
this end, cultured CD4 T cells with TCR activation were infected
with HIV in the presence of DMSO or ATM inhibitor for 3, 5,
and 7 days, followed by measuring active caspase-3, active
caspase-1, and GPX4 expressions for cell apoptosis, pyroptosis,
and ferroptosis, respectively. In line with their telomere length
and hTERT/pAKT/pATM levels (Figures 6A–D), healthy CD4
T cells treated with ATMi exhibited an increase in the active
caspase-3 and active caspase-1 expression levels, but a decrease
in the GPx4 expression compared to those treated with DMSO
(Figures 6I–K, 2 vs. 1). Similar to our observations shown in
Figure 1, HIV infection promoted CD4 T cell apoptosis,
pyroptosis, and ferroptosis, as evidenced by the increase in the
levels of active caspase-3 and active caspase-1, and the decrease
in GPx4 expression (Figures 6I–K, 3 vs. 1). However, ATMi
treatment resulted in a partial recovery of these effectors,
especially at day 5-7 after HIV infection and ATMi treatment
(Figures 6I–K, 4 vs. 3). Also, we analyzed programmed cell death
in productively infected cells and bystander cells in HIV culture.
Again, as we observed a survival potential in productively
infected cells (Figure 1), and noticed that p24+ cells exhibited
similar or lower levels of cell apoptosis, pyroptosis, and
ferroptosis than p24 - cells in HIV cultures with DMSO
treatment (Figures 6L–N, 7 vs. 5) and with the ATMi
treatment (Figures 6L–N, 8 vs. 6). However, compared with
DMSO treatment of HIV-infected cultures, ATMi treatment
resulted in a partial rescue of cell death in both p24- cells and
p24+ cells, especially at day 5–7 of HIV infection with ATMi vs.
DMSO treatment (Figures 6L–N, 6 vs. 5 and, 8 vs. 7).
We have previously shown that ATM inhibition induces
telomeric DNA damage, PI3K/AKT inhibition, and apoptotic
death in healthy CD4 T cells (14, 15). Why ATM inhibition
elicits an opposite effect in HIV-infected CD4 T cells remains
unknown. Since HIV infection in the setting of TCR stimulation
induces DNA damage and cell apoptosis (14, 15), and since ATM
activation serves as a marker for early DDR (10–12), we further
hypothesized that ATM inhibition could inhibit T cell activation,
and thus HIV infection as well as subsequent DDR. To test this

Inhibition of the ATM Pathway Promotes
Survival of HIV-Infected Cells and Rescues
AKT/Telomerase Activities via Inhibiting
HIV Infection and DDR
We have previously shown that ATM is not only a marker for
DDR (10–17), but also a marker for T cell activation, as
demonstrated by the close correlation between pATM and
pAKT and hTERT expression patterns during T cell activation
and HIV infection (Figure 4). Therefore, we hypothesized that
inhibition of the ATM pathway would suppress T cell activation,
HIV infection, and DDR. To test this hypothesis, we activated
CD4 T cells by anti-CD3/CD28 stimulation, followed by HIV
infection in the presence of DMSO or ATM inhibitor (ATMi, 10
mM KU60019) for 3, 5, and 7 days, and then measured the
telomere length, and hTERT, pAKT, and pATM expressions. As
we reported previously (14, 15), healthy CD4 T cells treated with
ATMi showed inhibition of telomere length, and
correspondingly, the expression levels of hTERT, pAKT and
pATM were inhibited in uninfected cells by ATMi compared to
those treated by DMSO (Figures 6A–D, 2 vs. 1). Similar to the
results described above (Figures 3, 4), HIV infection promoted
telomere erosion, along with inhibition of hTERT, pAKT, and
pATM expressions (Figures 6A–D, 3 vs. 1). However, ATMi
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FIGURE 5 | HIV Gag protein shortens telomere length by diminishing telomerase, AKT, and ATM activities in primary CD4 T cells. (A–F) Primary CD4 T cells were incubated with supernatants derived from 7-day
culture of HIV-infected or uninfected cells in the presence of HIV-entry blockers (Enfuvirtide and Maraviroc) for 3, 5, and 7 days, followed by measuring telomere length, telomerase, pAKT, pATM, gH2AX, and Av/
7AAD by ﬂow cytometry. (G) Representative overlaid histograms and summary data of the median ﬂuorescence intensity (MFI) of telomere length in Gag-treated and untreated CD4 T cells at days 3, 5, and 7,
measured by Flow-FISH. (H–J) Representative dot plots and summary % of the hTERT, pAKT, and pATM expressions in Gag-treated and untreated CD4 T cells at days 3, 5, and 7. (K–M) Positive correlation
between the MFI of telomere length and the % of hTERT, pATM, and hTERT, as well as pATM expression and telomere length in CD4 T cells with or without Gag treatment. (N–P) Summary data of the % of
CD25+, gH2AX+, and Av+ cells in CD4 T cells treated with or without HIV Gag.
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FIGURE 6 | ATM blockade promotes HIV-infected cell survival via rescuing AKT and telomerase activities by inhibiting HIV infection and DNA damage response (DDR). (A–D) HIV-infected and uninfected CD4 T
cells were treated with DMSO control or ATM inhibitor for 3, 5, and 7 days, followed by measuring telomere length, hTERT, pAKT, and pATM by ﬂow cytometry. (E–H) Summary data of the MFI of telomere length,
the % of hTERT, pAKT, and pATM expressions in p24+ and p24- cells following HIV infection with ATMi or DMSO treatment for 3, 5, and 7 days. (I–K) Summary data of the % of active caspase-3, active caspase-1,
and GPX4 expressions in HIV-infected and uninfected CD4 T cells treated with DMSO or ATMi for 3, 5, and 7 days. (L–N) Summary data of the % of active caspase-3, active caspase-1, and GPX4 expressions in
p24+ and p24- cells following HIV infection with ATMi or DMSO treatment for 3, 5, and 7 days.
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hypothesis, cultured CD4 T cells with TCR activation were
infected with HIV in the presence of DMSO or ATM inhibitor
(ATMi, 10 mM KU60019) for 3, 5, and 7 days, followed by
measuring the levels of T cell early activation marker CD25, HIV
infection marker p24, and DNA damage marker gH2AX. Indeed,
HIV infection was inhibited by ATMi treatment, as evidenced by
the signiﬁcant decrease p24+ cell frequency (Figure 7A). This
repressed HIV infection is likely related to ATMi-mediated
inhibition of CD4 T cell activation that is a prerequisite of
HIV infection, and the representative graphs of CD25 and
gH2AX was shown in (Figure 7B), as shown by the overall
decrease in CD25 expression in HIV-inhibited cells (Figure 7C,
3 vs. 1). ATMi also inhibited T cell activation in uninfected
cells (Figure 7C, 2 vs. 1). However, ATMi treatment partially
restored CD25 expression in HIV-infected cells at days 5-7
(Figure 7C, 4 vs. 3) in both p24- and p24+ cells (Figure 7D, 6
vs. 5, and 8 vs. 7). Correspondingly, gH2AX expression was
increased by HIV infection (Figure 7E, 3 vs. 1), and ATMi
treatment increased gH2AX levels in uninfected cells (Figure 7E,
2 vs. 1), but decreased it in HIV-infected cells (Figure 7E, 4 vs. 3)
in both p24- and p24+ cells (Figure 7F, 6 vs. 5, and 8 vs. 7). Taken
together, these results suggest that inhibition of the ATM
pathway promotes the death of healthy CD4 T cells but
protects survival of HIV-infected cells by regulating T cell
activation, DDR, and HIV infection.

proteins. Telomere integrity is a key feature of linear
chromosomes that preserves genome stability and function,
whereas telomere attrition is a hallmark of cellular senescence
that drives cell dysfunction or apoptosis (36, 37). Telomerase is
essential for maintaining the replicative capacity of T cells by
preserving shortening of telomere length and thereby cell
senescence (38, 39). The hTERT is the catalytic subunit of
telomerase and its expression positively correlates with
telomerase activity in human cells (38, 39). Notably, hTERT
nuclear translocation and activity depend upon AKT activation
(40, 41), which is closely associated with ATM activation, as we
observed in this current study (Figure 4). Therefore, blocking the
ATM pathway will lead to inhibition of AKT and T cell
activation, and subsequent HIV infection and DDR. This is in
line with previous reports showing that hTERT can protect cells
from apoptosis, in addition to protecting them from senescence,
and hTERT has also been used to immortalize cells for long-term
survival (42, 43).
HIV induces telomerase activity in macrophages, conferring
resistance to oxidative stress and possibly safeguarding one of its
known reservoirs (44). Our data suggest that early HIV infection
in CD4 T cells is also characterized by increased telomerase
activity, AKT/ATM activities, and telomere lengths in p24+ cells
compared to p24- cells, although all these activities eventually
trend down along with HIV infection compared to uninfected
cells. While cell death can still progress via any of the multiple
programmed cell death pathways (apoptosis, ferroptosis, and
pyroptosis), overall these p24+ cells appear to maintain telomeric
integrity (Figure 3F) more robustly than p24- bystander cells at
the early stage of HIV infection. Mechanistically, this integrity
appears to be supported by the AKT/ATM pathways, which
regulate telomerase activity and telomere dynamics, which are
upregulated in p24+ productively infected cells (Figures 3, 4).
Counterintuitively, blocking the ATM pathway abrogates the
HIV-induced inhibition of telomerase activity and telomere
length, particularly in the p24+ cells. This increased pAKT/
pATM activity in p24+ cells is not evident in p24- cells, and is
likely a response to the viral infection itself rather than to
exogenous exposure of inﬂammatory cytokines, soluble
antigens, or inhibitory molecules within the cellular milieu.
Could the preservation of telomeres upon initial infection
potentially favor HIV reservoir formation? Dynamically, infected
CD4 T cells undergo continual activation and integration of HIV
genetic components within the host cell genome. Only those cells
that survive cell death can go on to establish viral reservoirs. Thus,
preserving telomeric integrity has the potential to facilitate survival
of the infected cells and thus favors the establishment of HIV
reservoirs. Similar to our ﬁnding, Reynoso et al (44). reported
induction of telomerase activity in monocyte-derived macrophages
following HIV-1 infection, and these macrophages exhibited less
DNA damage after oxidative stress compared to the uninfected
cells. This effect on telomerase activity correlated with p24
production, and accordingly the authors proposed that HIV
“hitchhikes” on telomerase activity in macrophages to use the
cells as a reservoir. Our data support this proposal in that this proreservoir type of function may also occur in the CD4 T cell
population, but our study also suggests an initial increase in

DISCUSSION
The mechanisms involved in the death and survival of
productively infected CD4 T cells and bystander cells after
initial HIV infection are crucial for the depletion of CD4 T cells
and/or development of a replication-competent virus reservoir.
Here we focused on CD4 T cell death/survival dynamics following
initial HIV infection by infecting primary CD4 T cells with a
wild-type HIV-1 strain and assaying the cell death/survival
mechanisms, including telomeric dynamics and TCR signaling
pathways. Our ﬁndings suggest that HIV infection, in general,
promotes CD4 T cell programmed cell deaths, including
apoptosis, pyroptosis, and ferroptosis, but productively infected
cells behave differently compared to bystander cells, likely due
to activation of speciﬁc cellular survival/death programs
during early viral infection. Speciﬁcally, our data suggest that
productively infected cells exhibit greater telomere lengths and
express higher levels of hTERT, pAKT, and pATM upon initial
infection, indicating a possible pro-survival, pro-reservoir
mechanism at play during early HIV infection. Importantly,
blocking virus-entry into these cells attenuated HIV-induced
telomerase, pAKT, and pATM inhibition as well as telomere
erosion and cell death. Additionally, ATM inhibition promoted
survival of HIV-infected (especially p24+) cells via rescuing
telomere length and telomerase and AKT activities by
inhibiting T cell activation, HIV infection, and DDR, thus
reﬂecting CD4 T cell survival and death machineries during
HIV infection.
Telomeres are repeating hexameric sequences of DNA at
chromosome ends associated with a complex of shelterin
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FIGURE 7 | Blockade of ATM promotes HIV-infected cell survival via inhibiting T cell activation, HIV infection, and DNA damage. (A) p24 expression in HIV-infected CD4 T cells treated with DMSO or ATM inhibitor
(ATMi). (B–F) Summary data of the % of CD25 and gH2AX expressions in uninfected and HIV-infected (p24+ and p24-) CD4 T cells treated with DMSO or ATMi for 3, 5, and 7 days. (G) A schematic model of the
fate of productively infected CD4 T cells and bystander cells during early HIV infection. HIV promotes CD4 T cell death through enhancing various programmed cell death pathways, including apoptosis and
pyroptosis (especially in p24+ cells) or ferroptosis (especially in p24- cells) during early viral infection. Mechanistically, HIV infection promotes secretion of inﬂammatory cytokines as well as viral particles and proteins
(such as Gag) that can differentially regulate the pro- and anti-apoptotic proteins, such as Bad, pBad, Bcl-2, OX40, Nur77, Mcl-1, and Birc5, in p24+ and p24- cells. HIV infection also dysregulates T cell receptor
(TCR) signaling pathways, in particular PI3K (such as AKT/ATM) and telomerase hTERT activities, and thus affects telomere length and cell survival or death machineries in p24+ and p24- cells. While productively
infected (p24+) cells experience more death than p24- bystander cells, p24+ cells appear to exhibit survival activity, thus favoring HIV reservoir formation and latency establishment. Speciﬁcally, productively infected
CD4 T cells show prolonged telomeres, increased levels of telomerase, and more activated TCR signaling pathways compared to bystander CD4 T cells, indicating the involvement of cell survival and pro-reservoir
machineries during HIV infection. Importantly, blocking the ATM pathway promotes uninfected cell death but enhances virus-infected cell survival, and blocking HIV infection enhances overall cell survival, both
through regulating the signaling pathways involved in the maintenance of genomic telomere integrity. These results indicate that HIV-infected and uninfected cells employ different mechanisms for survival and death
during HIV infection.
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due to the fact, as our data show, that HIV-infected primary CD4
T cells suffered very dramatic and signiﬁcant cell death in the
cultural milieu and that generation of the reservoir cells is the
exception rather than the rule. The main strength of this study is
the use of primary cells and infectious HIV-1 virus to delineate
the differences and death/survival mechanisms between
productively HIV-1-infected cells and bystander cells instead
of cell lines and partial HIV-1 constructs; one limitation of this
study, however, is that there is no bridge to in vivo data, such as
ex vivo analysis of virus-infected and uninfected cells from HIV
patients. This is simply because we could not detect p24 antigens
in CD4 T cells derived from HIV-infected patients presenting
with speciﬁc viral loads (HIV RNA levels) due to the interruption
of ART.
In summary, our study uncovered that HIV infection induces
rapid and dramatic cell death in both productively infected and
bystander cells, and this cell death is associated with loss of
telomeric integrity via dysregulation of the telomerase and PI3K
pathways. However, survival signaling by the AKT, ATM, and
hTERT pathways are activated in productively infected CD4 T
cells and appears to drive the maintenance of telomere integrity.
Future studies will focus on delineating how this survival
signaling mechanism promotes the formation of viral
reservoirs, on revealing events that can prevent the
establishment of latent infection, and on interrupting the virus
cycle to eliminate reservoirs and cure HIV.

telomere length in infected CD4 T cells that was not observed in
macrophage. A recent study using a latency model of HIV infection
has also suggested that HIV peptide-induced, reactivated p24+ CD4
T cells express higher levels of hTERT and pAKT (45). However,
our studies were carried out in a more through, calculated, kinetic
and rigid way to demonstrate this notion, again highlighting a
potential survival mechanism for productively infected CD4 T cells
to drive HIV reservoir formation.
As noted above, activation of AKT and ATM signaling
differed signiﬁcantly in productively infected cells compared to
bystander cells and correlated quite well with both hTERT and
telomere lengths. The PI3K/Akt pathway is known to be a key
pathway for cell survival (46–48). Speciﬁcally, tuning of the AKT
pathway by HIV Nef and its blockade by protease inhibitors has
been shown to limit HIV-1 recovery from a latently infected T
cell line (49). Our data suggest that persistent inhibition of the
AKT and ATM pathways by HIV Gag results in decreased
telomerase activity and telomere length that favors cell death,
whereas the activation of the PI3K/AKT and ATM survival
pathways early on during HIV infection may maintain
telomeric integrity in a milieu that otherwise clearly favors cell
survival. Based on these data, we propose a model for early HIV
infection (Figure 7G) that supports the differential effects
observed in p24+ vs. p24- CD4 T cells. According to this
model, a signiﬁcant death in both cell populations occurs via
multiple death programs, including apoptosis, necroptosis, and
pyroptosis. We demonstrate that p24+ CD4 T cells exhibit
protective survival signaling, in particular, via the pAKT/
pATM pathways that promote maintenance of telomere length
compared to bystander T cells. However, there is clear evidence
of telomere shortening and impaired AKT/ATM pathways in
bystander CD4 T cells, perhaps driven by viral antigens such as
HIV Gag and/or the inﬂammatory cytokine milieu in the culture
system. Indeed, we have revealed, by two independent cytokine
array assays, that HIV-infected CD4 T cells can secrete
signiﬁcantly higher levels of multiple pro-inﬂammatory
cytokines into cultures over time, including IL-1a, IL-18,
TNFB, fractalkine, and GCSF, but release lower levels of other
mediators such as IL-10 and sCD40L. We have also discovered
considerable PD-1 expressions on the surface of HIV-infected
cells compared to uninfected cells (data not shown), suggesting
both soluble factors and direct cell-cell contact mediated
inhibitory mechanisms are possibly involved in the effects of
productively infected cells on bystander cells. This paradigm
warrants further studies.
Our study focused on primary CD4 T cells rather than latent
cell lines, and thus has limitations inherent to examining early
HIV infection. Cell infectivity was based upon the presence of
p24 antigen positivity, and it is possible that at least some cells
were at the very early stage of productive infection and did not
produce sufﬁcient p24. Also, due to limitations in p24 antibody’s
background and sensitivity, the number of infected cells could be
over- or under-estimated. However, as a whole, some delineation
must occur to separate populations and this measure appears
reasonable. We also did not assess the extent of HIV reservoir
formation over time in our primary cell cultures, focusing only
on the initial events after HIV infection. This was in large part
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